Clinical ScientistPfizer IncSouth San Francisco, California, United States
Disclosure information not submitted.
Over 4 Years of Safety and Efficacy With Voxelotor in Patients with Sickle Cell Disease
Sunday, June 9, 20241:33 PM – 1:51 PM ET